Double-blind, randomized, clinical trial of topiramate versus sodium valproate for the treatment of bipolar disorder in adolescents

Pakistan Journal of Medical Sciences

Volumn 25, Issue 2, 2009, Pages 247-252

  Hebrani, Paria ^a,b   Behdani, Fatemeh ^a   Manteghi, Ali Akhoondpoor ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bipolar; Child and adolescent; Sodium valproate; Topiramate

Indexed keywords

TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; BIPOLAR I DISORDER; BIPOLAR MANIA; BLURRED VISION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HAIR LOSS; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIXED MANIA AND DEPRESSION; MONOTHERAPY; MUSCLE WEAKNESS; NAUSEA; PARESTHESIA; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SPEECH DISORDER; TREMOR; YOUNG MANIA RATING SCALE;

EID: 66549120041     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Geller B, Zimmerman B, Williams M, Bolhofner K, Craney JL, DelBello MP, et al. Diagnostic characteristics of 93 cases of prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 2000;10:157-164
2. Perlis RH, Miyahara S, Marangell LB. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEPBD). Biol Psychiatry 2004;55:875-881 (Pubitemid 38526299)
3. Craney JL, Geller B. A prepubertal and early adolescent bipolar disorder-I phenotype: review of phenomenology and longitudinal course. Bipolar Disorders 2003;5:243-256 (Pubitemid 37009888)
4. Wagner KD. Management of bipolar disorder in children and adolescents. Psychopharmacol Bull: 2002a;36:151-159
5. Bowden CL, Brugger AM, Swamm AC. Efficacy of divalproex vs. lithium and placebo in the treatment of mania. JAMA 1994;271:918-924 (Pubitemid 24083217)
6. Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Amer J Psych 2002;159:1146-1154 (Pubitemid 34743254)
7. Gibbs JW 3rd, Sombati S, DeLorenzo RJ, Coulter DA. Cellular actions of Topiramate: blockade of kainite-evoked inward currents in cultured hippocampal neurons. Epilepsia: 2000;41:(supplement1)S10-S16.
8. Kuzniecky R, Hetherington H, Ho S, Pan J, Martin R, Gilliam F. Topiramate increases cerebral GABA in healthy humans. Neurology 1998;51:627-629 (Pubitemid 28406359)
9. White HS. Mechanism of action of newer anticonvulsants. J Clin Psychiatry 2003;64(suppl 8):5-8. (Pubitemid 36903901)
10. Kushner SF, Khan A, Lane R, HOlson W. Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials, Bipolar Disorders 2006;8:15-27. (Pubitemid 43356017)
11. Bozikas VP, Petrikis P, Kourtis A, Youlis P, Karavatos A. Treatment of acute mania with topiramate in hospitalized patients. Prog Neuro-psychopharmacol Biol Psychiatry 2002;26:1203-1206 (Pubitemid 35256117)
12. Calabrese JR, Keck Jr, McElroy SL, Shelton, A pilot study of topiramate as monotherapy in the treatment of acute mania. J Clincal Psychopharmacology 2001;21:340-342 (Pubitemid 32452941)
13. Ghaemi SN, Manwani SG, Katzow JJ, Ko JY, Goodwin FK. Topiramate treatment of bipolar spectrum disorders: a retrospective chart review. Ann Clin Psychiatry 2001;13:185-189 (Pubitemid 34273558)
14. Guille C, Sachs G. Clinical outcome of adjunctive topiramate treatment in a sample of refractory bipolar patients with comorbid conditions. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:1035-1039 (Pubitemid 35256094)
15. Wozniak J, Biederman J, Richards JA. Diagnostic and therapeutic dilemmas in the management of pediatric- onset bipolar disorder. J Clin Psychiatry 2001;62(suppl 14):10-15. (Pubitemid 32591413)
16. DelBello MP, Kowatch RA, Warner J. Adjunctive topiramate treatment for pediatric bipolar disorder: a retrospective chart review. J Child Adolesc Psychopharmacol 2002a;12:323-330 (Pubitemid 36169284)
17. DelBello MP, Schwiers ML, Rosenberg HL, Strakowski SM. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J American Academy of Child & Adolescents Psychiatry 2002b;41:1216-1223 (Pubitemid 38338041)
18. Delbello MP, Findling RL, Kushner S, Wang D, Olson WH, Capece JA. A Pilot Controlled Trial of Topiramate for Mania in Children and Adolescents with Bipolar Disorder. J Amer Academy Child Adolescent Psych 2005;44(6):539-547 (Pubitemid 40720953)
19. Ghanizadeh A, Mohammadi MR, Yazdanshenas A. Psychometric properties of the Farsi translation of the Kiddy Schedule for Affective Disorders and schizophrenia-Present and Lifetime Version. Bio Med Central Psychiatry 2006;6:10 20. (Pubitemid 43983120)
20. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-435 (Pubitemid 9006756)
21. Schaffer D, Gould MS, Brasic J. A children's global assessment scale (CGAS). Archives General Psychiatry 1983;40:1228-1231
22. Wagner KD, Weller EB, Carlson GA. An open-label trial of divalproex in children and adolescents with bipolar disorder. J Amer Academy Child Adolescents Psychiatry 2002;41:1224-1230 (Pubitemid 38338042)
23. Kowatch RA, Suppes T, Carmody TJ. Effect size of lithium, divalproex sodium and carbamazepine in children and adolescents with bipolar disorder. J Amer Academy Child Adolescents Psychiatry 2000;39:713-720 (Pubitemid 30351221)
24. Pavuluri MN, Henry DB, Carbray JA, Naylor MW, Janicak PG. Divalproex sodium for pediatric mixed mania: a 6-month prospective trial. Bipolar Disord 2005;7(3):266-273 (Pubitemid 40778889)
25. Rana M, Khanzode L, Karnik N, Saxena K, Chang K, Steiner H. Divalproex sodium in the treatment of pediatric psychiatric disorders, Expert Review of Neurotherapeutics: 2005;5(2):165-176 (Pubitemid 40445139)
26. Levisohn PM. Safety and tolerability of topiramate in children. J Child Neurol 2001;5(suppl 1):S22-S26.